MRI Investigations in Attention Deficit Hyperactivity Disorder (ADHD) and High Potential (HP) Children for a Better Therapeutic Approach

NCT ID: NCT02823782

Last Updated: 2016-07-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-05-31

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Impulsivity and/or hyperactivity in children has become one of the main clinical symptom for consultation, among the most frequent, in general or pediatric medicine. Among the different clinical forms of instability, ADHD appears to be an especially disabling condition for the development of the child, both in psychomotor, cognitive, emotional and relational aspects. Further, a significant link between ADHD children and some children with High Potential (HP) is observed. HP children show overall ahead cognitive developments compared to children with the same age. In these children, as well as in children with ADHD, an attention vulnerability, psychomotor deficits are noted, as well as emotional and relational deficits that significantly contrasted with some of their cognitive skills. Regarding the HP, the hypothesis is that children with significantly heterogeneous results (Complex) to the Wechsler IV scales are affected by this shift, and hence, by the difficulty of a differential diagnosis with ADHD, unlike those whose intelligence quotient (IQ) results that are more homogeneous (Laminar).

The goal of this work was to study a population of 80 children aged from 8 to 12 years (20 subjects per group) to evaluate the functional and structural brain development by:

* Functional magnetic resonance imaging (fMRI) acquisitions with cognitive stimulations, involving attention, working memory and semantic processing, and emotional stimulations,
* fMRI acquisitions at rest (without activation),
* diffusion tensor magnetic resonance imaging (DTI) acquisitions,
* 3D anatomic acquisitions. Identification of developmental differences in certain cortical brain areas (eg, prefrontal vs parietal), white matter fiber bundles or functional networks preferentially used by one or other of these groups, will help to better understand this disease, and to improve the differential diagnosis in order to implement a more appropriate and personalized management of the patients via new therapeutic strategies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ADHD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Laminar HP

Structural and functional MRI markers

Group Type EXPERIMENTAL

MRI

Intervention Type OTHER

MRI and neuropsychological assessment planned for the study for patient and volunteers

neuropsychological assessment

Intervention Type OTHER

Complex HP

Structural and functional MRI markers

Group Type EXPERIMENTAL

MRI

Intervention Type OTHER

MRI and neuropsychological assessment planned for the study for patient and volunteers

neuropsychological assessment

Intervention Type OTHER

ADHD

Structural and functional MRI markers

Group Type EXPERIMENTAL

MRI

Intervention Type OTHER

MRI and neuropsychological assessment planned for the study for patient and volunteers

neuropsychological assessment

Intervention Type OTHER

Control

Structural and functional MRI markers

Group Type OTHER

MRI

Intervention Type OTHER

MRI and neuropsychological assessment planned for the study for patient and volunteers

neuropsychological assessment

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI

MRI and neuropsychological assessment planned for the study for patient and volunteers

Intervention Type OTHER

neuropsychological assessment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Right-hand 4 groups :
* Laminar HP : IQ \> 130 and difference between Verbal Comprehension Index (VCI) and Perceptual Reasoning Index (PRI) \< 9
* Complex HP : IQ \> 130 and difference between VCI and PRI \>15
* ADHD : 90 \< IQ \<110
* Controls : 90 \< IQ \<110

Exclusion Criteria

* Subjects with any psychiatric disorders except ADHD,
* Subjects with known learning deficits (dyslexia, dysphasia…), attention deficits except for ADHD group
* Subjects with claustrophobia or magnetic devices
* Children with out both parental agreements
Minimum Eligible Age

8 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olivier REVOL, MD

Role: PRINCIPAL_INVESTIGATOR

HCL

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de psychiatrie infantile, Hôpital Pierre Wertheimer, 59 Boulevard Pinel

Bron, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-805

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.